newsfilter
← Latest News
Business Wire·

Tempus Expands Strategic Collaboration with Bristol Myers Squibb

Tempus AI, Inc. (NASDAQ:TEM, "Tempus")) today announced a multi-year agreement with Bristol Myers Squibb (NYSE:BMY, "BMS")), under which BMS will license multimodal oncology data from Tempus through 2031